Prelude Capital Management’s ICU Medical ICUI Stock Holding History

Prelude Capital Management’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-302	Closed	-$55K	–	1596
2020 Q3	$55K	Sell	302 -484	-62%	-$91.1K	﹤0.01%	1096
2020 Q2	$145K	Buy	+786	New	+$156K	0.01%	830
2018 Q2	–	Sell	-30	Closed	-$8K	–	1780
2018 Q1	$8K	Buy	+30	New	+$7.05K	﹤0.01%	1374
2016 Q2	–	Sell	-211	Closed	-$22K	–	1642
2016 Q1	$22K	Buy	+211	New	+$20.2K	﹤0.01%	1102
2015 Q4	–	Sell	-110	Closed	-$12K	–	1556
2015 Q3	$12K	Sell	110 -362	-77%	-$38.7K	﹤0.01%	1327
2015 Q2	$45K	Buy	+472	New	+$44.1K	0.01%	1178
2015 Q1	–	Sell	-400	Closed	-$33K	–	2035
2014 Q4	$33K	Buy	+400	New	+$30.7K	﹤0.01%	1590
2013 Q4	–	Sell	-30	Closed	-$2K	–	1746
2013 Q3	$2K	Buy	+30	New	+$2.14K	﹤0.01%	1669

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Prelude Capital Management's ICUI Position: Q4 2020 in Review

Prelude Capital Management sold out of ICU Medical (ICUI) in Q4 2020, closing a stake of 302 shares — an estimated $55K sold.

Prelude Capital Management first reported a position in ICUI in Q3 2013 and held it in 8 quarters. The position peaked at $145K in Q2 2020. 284 funds tracked by Wall St. Rank hold ICUI as of Q4 2020.

Prelude Capital Management reported no remaining ICU Medical position as of Q4 2020 after selling out during the quarter.
Prelude Capital Management sold 302 ICU Medical shares in Q4 2020, an estimated $55K.
Prelude Capital Management first reported a position in ICU Medical in Q3 2013 and held it in 8 quarters.
Prelude Capital Management's ICU Medical position peaked at $145K in Q2 2020.
284 funds tracked by Wall St. Rank held ICU Medical as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.